Two Rubrik insiders filed Form 4s on the same day, with CFO Kiran Kumar Choudary selling shares between $99.08 and $108.05.
Two insiders at Rubrik (RBRK) filed Form 4 statements with the SEC on the same day, disclosing open-market transactions with a combined value of roughly $1.05 million. All of the reported sales were made by one of the two filers, at prices ranging from $99.08 to $108.05 per share.
Tadaa Technology will supply the AI backbone for a 1,000-acre solar farm feeding a data centre under a 25-year power arrangement, targeting $7.3M in annual revenue.
Alpha Compute has signed definitive agreements for Utica and Marcellus acreage with more than 75 wells, and plans to build a data center on the site.
Palisade Bio can start the Phase 2 ASCENTRA-CD trial of its oral PDE4 prodrug, with first dosing targeted for Q1 2027 and a primary readout in Q1 2028.
VERSATILE-002 results for PDS0101 plus pembrolizumab show 39.3 months median overall survival in checkpoint-inhibitor-naive HPV16-positive head and neck cancer.
